Product Information
OSCIMIN SL 0.125 MG TABLET is a generic product labeled by Larken Laboratories, Inc., priced at $0.1707 per EA under NDC 68047025301. Its NADAC has been published 671 times since Nov 28, 2013.
Strength
.125 mg/1
Manufacturer
Larken Laboratories, Inc.NDC
68047025301
Classification
Generic
Dosage Form
TABLET, ORALLY DISINTEGRATING
Route
SUBLINGUAL
Effective Date
9/23/2026
Active Ingredients
HYOSCYAMINE SULFATEApproval Type
Unapproved
On Market Since
8/3/2011
Price Statistics
The NADAC for OSCIMIN SL 0.125 MG TABLET has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 48.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1707 per EA |
|---|---|
| All-time high | $0.3345 (Jan 15, 2014) |
| All-time low | $0.1095 (Sep 21, 2022) |
| 52-week high | $0.2188 |
| 52-week low | $0.1707 |
| Median price | $0.1828 |
| Average price | $0.1884 |
| Largest weekly change | +29.2% (Feb 18, 2015) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 15% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Larken Laboratories, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Hyoscyamine Sulfate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of OSCIMIN SL 0.125 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for OSCIMIN SL 0.125 MG TABLET, manufactured by Larken Laboratories, Inc., is $0.1707 per EA (NDC 68047025301), effective Sep 30, 2026.
How has the price of OSCIMIN SL 0.125 MG TABLET changed over time?
Over the history we have for it, the NADAC for OSCIMIN SL 0.125 MG TABLET has declined 48.1%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for OSCIMIN SL 0.125 MG TABLET?
Since Nov 28, 2013, the NADAC for OSCIMIN SL 0.125 MG TABLET has ranged from a low of $0.1095 (Sep 21, 2022) to a high of $0.3345 (Jan 15, 2014), with a median of $0.1828 per EA.
Are there cheaper alternatives to OSCIMIN SL 0.125 MG TABLET?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, HYOSCYAMINE 0.125 MG ODT, is $0.1442 per EA — about 15% below OSCIMIN SL 0.125 MG TABLET.
Who manufactures OSCIMIN SL 0.125 MG TABLET?
OSCIMIN SL 0.125 MG TABLET (NDC 68047025301) is labeled by Larken Laboratories, Inc., and CMS classifies it as a generic product.